Efficacy and safety of neoadjuvant chemotherapy regimens for triple-negative breast cancer: a network meta-analysis

Different neoadjuvant chemotherapies are available for triple-negative breast cancer (TNBC). Here, we performed a network meta-analysis to evaluate the pathological complete response (pCR) benefit and safety of treatment regimens. Pairwise and Bayesian network meta-analyses were performed to compare...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yunhai, Yang, Dejuan, Chen, Ping, Yin, Xuedong, Sun, Jiazheng, Li, Hongzhong, Ren, Guosheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738404/
https://www.ncbi.nlm.nih.gov/pubmed/31446432
http://dx.doi.org/10.18632/aging.102188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738404/
https://www.ncbi.nlm.nih.gov/pubmed/31446432
http://dx.doi.org/10.18632/aging.102188

Ejemplares similares